Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hyperion Therapeutics completes acquisition of Andromeda Biotech, Ltd.


Thursday, 12 Jun 2014 08:46am EDT 

Hyperion Therapeutics Inc:Completes acquisition of Andromeda Biotech Ltd.Andromeda became a wholly owned subsidiary of Hyperion Therapeutics in exchange for $12.5 mln in cash, less adjustments for expenses incurred in connection with the transaction, and 312,869 shares of Hyperion common stock. 

Company Quote

45.97
-0.03 -0.07%
4:00pm EDT